Tetsuro Tachi,Noriyuki Kijima,Hideki Kuroda,Syunya Ikeda,Koki Murakami,Tomoyoshi Nakagawa,Moto Yaga,Kanji Nakagawa,Reina Utsugi,Ryuichi Hirayama,Yoshiko Okita,Naoki Kagawa,Haruhiko Kishima,Chihaya Imai,Naoki Hosen

Abstract:Glioblastoma multiforme (GBM) is the most lethal primary brain tumor for which novel therapies are needed. Recently, chimeric antigen receptor (CAR) T cell therapy has been shown to be effective against GBM, but it is a personalized medicine and requires high cost and long time for the cell production. CAR-transduced natural killer (NK) cells can be used for "off-the-shelf" cellular immunotherapy because they do not induce graft-versus-host disease. Therefore, we aimed to analyze the anti-GBM effect of CAR-T or NK cells targeting B7-H3, which is known to be highly expressed in GBM.

Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model